Dr. Patrick Katoto received his medical degree cum laude from Ngozi University (Burundi) and Catholic University of Bukavu-UCB (DR Congo) where he works as academic and clinician in internal medicine.
He performed further clinical training at the Catholic University of Louvain in Brussels (Belgium) and an MSc in Clinical Epidemiology at Stellenbosch University (South Africa). His MSc focused on traditional and emerging risk factors for HIV-associated metabolic syndrome. He subsequently completed the three levels of the Pan African Thoracic Society – Methods in Epidemiologic, Clinical and Operations Research (PATS-MECOR) course, and received the 2016 American Thoracic Society (ATS) Foundation MECOR Award. He was thereafter selected as faculty in the ATS/PATS-MECOR program (2018).
He is interested on Global Health, and has completed the Advanced Certificate in Improving Global Health focusing on quality and safety from Harvard University (USA).
Dr. Katoto was awarded the Marc Vervenne Fund fellowship for his PhD research at Katholiek University of Leuven (Belgium). He combined animal models, clinical-epidemiology and research synthesis methods to assess the attributable risk of environmental air pollution, pulmonary tuberculosis (TB) and chronic cough in post-TB patients.
He also evaluated the association between hallmarks of earlier cellular senescence (telomere length and mtDNA) and TB treatment outcomes among HIV-infected persons. Dr. Katoto is committed to a career in HIV-comorbidities in sub-Saharan Africa, especially in areas of cardio-pulmonary, HIV-AIDS, and Household Air Pollution (HAP). For his NIH-Fogarty Pitt-HRTP-SA postdoc, he is investigating the effect of HIV status on the severity of Pulmonary Hypertension-Left Heart Diseases (PH-LHD), in Africa.
Dr. Katoto is also co-investigator on the baseline for sepsis in Africa study (Liverpool School of Tropical Medicine) and the Statin-TB (University of Cape Town).
URL
https://orcid.org/0000-0002-0553-201X
